Cargando…
Safety and efficacy of peramivir for influenza treatment
OBJECTIVE: This report presents a review of the efficacy and safety of peramivir, a neuraminidase inhibitor that was granted Emergency Use Authorization by the US Food and Drug Administration (FDA) from October 23, 2009 to June 23, 2010 during the 2009 H1N1 pandemic. METHODS: Literature was accessed...
Autores principales: | Hata, Atsuko, Akashi-Ueda, Ryoko, Takamatsu, Kazufumi, Matsumura, Takuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216046/ https://www.ncbi.nlm.nih.gov/pubmed/25368514 http://dx.doi.org/10.2147/DDDT.S46654 |
Ejemplares similares
-
Peramivir for influenza
Publicado: (2019) -
A Meta-Analysis Comparing the Efficacy and Safety of Peramivir with Other Neuraminidase Inhibitors for Influenza Treatment
por: Chen, Jui-Yi, et al.
Publicado: (2020) -
Peramivir injection in the treatment of acute influenza: a review of the literature
por: Wester, Ashley, et al.
Publicado: (2016) -
Clinical Effectiveness and Safety of Peramivir for Influenza Infection: Safe and Effective Antiviral Treatment
por: Lee, Jin Seo
Publicado: (2018) -
Pathogenicity and peramivir efficacy in immunocompromised murine models of influenza B virus infection
por: Pascua, Philippe Noriel Q., et al.
Publicado: (2017)